Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer
Reports outline cancer study findings from Rutgers University
May 7th, 2009
"Numerous preclinical, epidemiologic, and clinical studies have suggested the benefits of vitamin D and its analogues for the prevention and treatment of cancer. However, the hypercalcemic effects have limited the use of 1 alpha,25(OH)(2)D-3, the hormonally active form of vitamin D. To identify vitamin D analogues with better efficacy and low toxicity, we have tested >60novel Gemini vitamin D analogues with a unique structure of two side chains for growth inhibition of breast cancer cells," scientists in the United States report. "Our initial studies found that some Gemini analogues are 5-15 times more active than 1 alpha,25(OH)(2)D-3 in growth inhibition assay. In...
Source: Women's Health Weekly (2009-05-07)
|
